GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RP Bio lnc (XKRX:314140) » Definitions » Current Accrued Expense

RP Bio lnc (XKRX:314140) Current Accrued Expense : ₩0 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is RP Bio lnc Current Accrued Expense?

RP Bio lnc's Current Accrued Expense for the quarter that ended in Mar. 2024 was ₩0 Mil.


RP Bio lnc Current Accrued Expense Historical Data

The historical data trend for RP Bio lnc's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RP Bio lnc Current Accrued Expense Chart

RP Bio lnc Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Current Accrued Expense
- - - -

RP Bio lnc Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

RP Bio lnc Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


RP Bio lnc Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of RP Bio lnc's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


RP Bio lnc (XKRX:314140) Business Description

Traded in Other Exchanges
N/A
Address
634, Samseong-ro, Gangnam-gu, Seoul, KOR, 06084
RP Bio lnc is engaged in the pharmaceutical manufacturing business. It produces softgels, finished drugs, and other products.

RP Bio lnc (XKRX:314140) Headlines

No Headlines